XIENCE 28 Global Study

NCT03355742 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

963

Enrollment

INDUSTRY

Sponsor class

Conditions

Bleeding Disorder
Stroke, Ischemic
Stroke Hemorrhagic
Hematological Disease
Thrombocytopenia
Coagulation Disorder
Anemia
Renal Insufficiency
Coronary Artery Disease

Interventions

DEVICE: XIENCE
DRUG: DAPT

Sponsor

Abbott Medical Devices